6-thioguanosine and Anthrax

Germination of Bacillus anthracis spores into the vegetative form is an essential step in anthrax pathogenicity. This process can be triggered in vitro by the common germinants inosine and alanine. Kinetic analysis of B. anthracis spore germination revealed synergy and a sequential mechanism between inosine and alanine binding to their cognate receptors. Because inosine is a critical germinant in vitro, we screened inosine analogs for the ability to block in vitro germination of B. anthracis spores. Seven analogs efficiently blocked this process in vitro. This led to the identification of 6-thioguanosine, which also efficiently blocked spore germination in macrophages and prevented killing of these cells mediated by B. anthracis spores. 6-Thioguanosine shows potential as an anti-anthrax therapeutic agent.

Topics: Alanine; Animals; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Cells, Cultured; Dose-Response Relationship, Drug; Guanosine; Inhibitory Concentration 50; Inosine; Kinetics; Macrophages; Mice; Microscopy, Fluorescence; Spores, Bacterial; Thionucleosides